12 unchanged sentences
Form of Warrant to Purchase Common Stock issued to Investors in October 2019 Public Offering.
−Removed: 10.1 Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Bionano Genomics, Inc.
−Removed: 2018 Equity Incentive Plan
+Added: Form of Warrant to Purchase Common Stock issued to Investors in April 2020 Public Offering .
+Added: 10.1 Non-Employee Director Compensation Policy, as Amended.
31.1* Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
16 unchanged sentences
333-233828), as amended.
+Added: (6) Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (File No.
+Added: 333-237074), as amended.
* This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
1 unchanged sentence
BIONANO GENOMICS, INC.
−Removed: August 4, 2021
+Added: November 4, 2021
Erik Holmlin, Ph.D.
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 4, 2021
+Added: November 4, 2021
/s/ Christopher Stewart
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.